Synthetic coevolution reveals adaptive mutational trajectories of neutralizing antibodies and SARS-CoV-2
Roy A. EhlingiD, Mason MinotiD, Max D. OverathiD, Daniel J. ShewardiD, Jiami HaniD, Beichen GaoiD, Joseph M. TaftiD, Margarita PertsevaiD, Cédric R. WeberiD, Lester FreiiD, Thomas BikiasiD, Ben MurrelliD, Sai T. ReddyiD
Abstract
The Covid-19 pandemic showcases a coevolutionary race between the human immune system and SARS-CoV-2, mirroring the Red Queen hypothesis of evolutionary biology. The immune system generates neutralizing antibodies targeting the SARS-CoV-2 spike proteins receptor binding domain (RBD), crucial for host cell invasion, while the virus evolves to evade antibody recognition. Here, we establish a synthetic coevolution system combining high-throughput screening of antibody and RBD variant libraries with protein mutagenesis, surface display, and deep sequencing. Additionally, we train a protein language machine learning model that predicts antibody escape to RBD variants. Synthetic coevolution reveals antagonistic and compensatory mutational trajectories of neutralizing antibodies and SARS-CoV-2 variants, enhancing the understanding of this evolutionary conflict.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 10
- FWCI
- 6.11
- Field percentile
- top 3%
- Assay
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Clonal interference and changing selective pressures shape the escape of SARS-CoV-2 from hundreds of antibodies
Hugh K. Haddox, Omar Abdel Aziz, … Frederick A. Matsen IV·Virus EvolutionPeer-reviewed·Jan 1, 2026
- Insights on SARS-CoV-2's Mutations for Evading Human Antibodies: Sacrifice and Survival
- Evaluating SARS-CoV-2 Antibody Resilience via Prediction and Design of Escape Viral Variants
Marian Huot, Pierre Rosenbaum, … Simona Cocco·Cell SystemsPeer-reviewed·Jul 17, 2026
- Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape
F. Zhao, C. Keating, … J. G. Jardine·bioRxiv·Jan 6, 2022
- Deep learning-guided selection of antibody therapies with enhanced resistance to current and prospective SARS-CoV-2 Omicron variants
L. Frei, B. Gao, … S. T. Reddy·bioRxiv·Oct 9, 2023
- Investigating the role of binding free energy, binding affinity and antibody escape in the evolution of SARS-CoV-2 spike protein.
M. Young, S. J. Lycett·bioRxiv·Oct 15, 2022